GeneMetrics - About the company
GeneMetrics is a deadpooled company based in Nairobi (Kenya), founded in 2013 by Anup Devani. It operates as a Provider diagnostic tests for infectious disease, human genetics and cancer genetics. The company has 112 active competitors, including 24 funded and 18 that have exited. Its top competitors include companies like Natera, LifeCell and Lantern Pharma.
Company Details
- Website
- genemetrics.co.ke
- Social
Key Metrics
Founded Year
2013
Location
Nairobi, Kenya
Stage
Deadpooled
Ranked
150th among 151 competitors
Employee Count
1 - 10 as on Jul 01, 2024
Sign up to download GeneMetrics' company profile
GeneMetrics's funding and investors
GeneMetrics has not raised any funding rounds yet.
GeneMetrics' founders and board of directors
Founder? Claim ProfileThe founders of GeneMetrics is Anup Devani.
Here are the details of GeneMetrics' key team members:
- Anup Devani: Founder & Managing Director of GeneMetrics.
View details of GeneMetrics's Founder profiles and Board Members
GeneMetrics' employee count trend
GeneMetrics has 1 - 10 employees as of Jul 24. Here is GeneMetrics's employee count trend over the years:
Uncover GeneMetrics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
GeneMetrics's Competitors and alternates
Top competitors of GeneMetrics include Natera, LifeCell and Lantern Pharma. Here is the list of Top 10 competitors of GeneMetrics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Natera 2004, Redwood City (United States), Public | Developer of cell-free DNA testing for oncology, women’s health, and organ health | $152M | 77/100 | |
2nd | A stem cell banking company specializing in cord blood and tissue preservation | $61.2M | 65/100 | ||
3rd |  Lantern Pharma 2013, Dallas (United States), Public | Developing drug and companion diagnostics for multi-drug resistant cancers | $7.12M | 62/100 | |
4th | GeneDx 2000, Gaithersburg (United States), Acquired | Provider of genetic testing for inherited disorders | - | 62/100 | |
5th |  Nucleus Genomics 2021, Manhattan (United States), Series A | Provider of genetic testing kits for rare variant analysis | $32M | 62/100 | |
6th | Provider of an AI based cancer therapy management software for researchers and doctors | $61.7M | 59/100 | ||
7th |  ArcherDX 2013, Boulder (United States), Acquired | Developer of molecular cancer diagnostic products | $153M | 58/100 | |
8th |  RareCyte 2009, Seattle (United States), Series C | Developer of technologies for the analysis of rare and single cells in the blood | $114M | 57/100 | |
9th |  Rgenta 2018, Cambridge (United States), Series A | Developer of RNA-based therapeutics for multiple disorders | $90M | 56/100 | |
10th | Sema4 2017, Stamford (United States), Public | Provider of genome-based diagnostic testing solutions for reproductive health and oncology | $241M | 56/100 | |
150th | GeneMetrics 2013, Nairobi (Kenya), Deadpooled | Provider diagnostic tests for infectious disease, human genetics and cancer genetics | - | - | 15/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on GeneMetrics's competitors? Click here to see the top ones
GeneMetrics's Investments and acquisitions
GeneMetrics has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about GeneMetrics
Explore our recently published companies
- Commspartner - Unfunded company
- Sherpa Consulting - Woodside based, 2016 founded, Unfunded company
- Techlan - Unfunded company
